Yuan Luo

Yuan Luo

Auto-generated profile, based on publicly available information

Yuan Luo

Laboratory of Aquaculture Nutrition and Environmental Health (LANEH), School of Life Sciences, East China Normal University, Shanghai, People’s Republic of China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
FZFan Zhang
Fan Zhang
QYQiuran Yu
Qiuran Yu
YHYuxing Huang
Yuxing Huang
YLYuan Luo
Yuan Luo
Jianguang QinJianguang Qin
Jianguang Qin
XWXiaodan Wang
Xiaodan Wang
Myo-inositol oxygenase (MIOX) is the rate-limiting enzyme that catalyzes the first step of MI metabolism and determines MI content in aquatic animals. To understand the role of miox in the osmotic regulation of Nile tilapia, we analyzed its expression in different tissues and its function under hyperosmotic stress. This study showed that miox is essential in osmotic regulation to enhance the salinity tolerance of Nile tilapia by affecting myo-inositol accumulation, glucose metabolism, and antioxidant performance.

1 September 2024 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
JWJun-Xian Wang
Jun-Xian Wang
YZYan-Yu Zhang
Yan-Yu Zhang
YQYu-Cheng Qian
Yu-Cheng Qian
YQYi-Fan Qian
Yi-Fan Qian
AJAn-Hui Jin
An-Hui Jin
Zhenyu DuZhenyu Du
Zhenyu Du
The mitochondrial citrate shuttle is a crucial physiological process for maintaining metabolic homeostasis. In the present study, we found that inhibition of mitochondrial citrate shuttle (Slc25a1) could alleviate metabolic syndromes induced by high-fat diet (HFD) through remodeling hepatic protein acetylation modification. Briefly, Slc25a1 inhibition reduces hepatic triglyceride deposition by deacetylating Cpt1a and reduces glucose oxidative catabolism by acetylating Pdhe1α. Our study provides new insights into the treatment of diet-induced metabolic syndromes.

8 September 2022 in Animal Feed Science and Technology
Verified
Journal Article
Closed access
JWJin-Gang Wang
Jin-Gang Wang
Samad RahimnejadSamad Rahimnejad
Samad Rahimnejad
YLYi-Chan Liu
Yi-Chan Liu
JRJiong Ren
Jiong Ren
FQFang Qiao
Fang Qiao
YLYuan Luo
Yuan Luo

1 March 2023 in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Verified
Journal Article
Closed access
PDF file
RLRui-Xin Li
Rui-Xin Li
LCLing-Yun Chen
Ling-Yun Chen
SLSamwel M. Limbu
Samwel M. Limbu
BYBing Yao
Bing Yao
YQYi-Fan Qian
Yi-Fan Qian
YLYuan Luo
Yuan Luo
The regulation of cholesterol metabolism in fish is still unclear. Statins play important roles in promoting cholesterol metabolism development in mammals. However, studies on the role of statins in cholesterol metabolism in fish are currently limited. The present study evaluated the effects of statins on cholesterol metabolism in fish. Nile tilapia ( Oreochromis niloticus) were fed on control diets supplemented with three atorvastatin levels (0, 12, and 24 mg/kg diet, ATV0, ATV12, and ATV24, respectively) for 4 wk. Intriguingly, the results showed that both atorvastatin treatments increased hepatic cholesterol and triglyceride contents mainly through inhibiting bile acid synthesis and efflux, and compensatorily enhancing cholesterol synthesis in fish liver ( P < 0.05). Moreover, atorvastatin treatment significantly inhibited hepatic very-low-density lipoprotein (VLDL) assembly and thus decreased serum VLDL content ( P < 0.05). However, fish treated with atorvastatin significantly reduced cholesterol and triglycerides contents in adipose tissue ( P < 0.05). Further molecular analysis showed that atorvastatin treatment promoted cholesterol synthesis and lipogenesis pathways, but inhibited lipid catabolism and low-density lipoprotein (LDL) uptake in the adipose tissue of fish ( P < 0.05). In general, atorvastatin induced the remodeling of lipid distribution between liver and adipose tissues through blocking VLDL efflux from the liver to adipose tissue of fish. Our results provide a novel regulatory pattern of cholesterol metabolism response caused by atorvastatin in fish, which is distinct from mammals: cholesterol inhibition by atorvastatin activates hepatic cholesterol synthesis and inhibits its efflux to maintain cholesterol homeostasis, consequently reduces cholesterol storage in fish adipose tissue.